| Reference |
|---|
Fahoum J, Billan M, Varga J, Padawer D, Britan Rosich Y, Elgrably Weiss M, et al. Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition. Cell Rep. 2025;44:115512 pubmed publisher |
Wang J, Ma Y, Li Z, Yuan H, Liu B, Li Z, et al. SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding. Sci Adv. 2025;11:eadr8772 pubmed publisher |
Adeleke R, Sahler J, Choi A, Roth K, Upadhye V, Ezzatpour S, et al. Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus. Sci Adv. 2025;11:eadq4545 pubmed publisher |
Ojha R, Jiang A, M xe4 ntyl xe4 E, Quirin T, Modhira N, Witte R, et al. Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal viruses. PLoS Pathog. 2024;20:e1012690 pubmed publisher |
Asgharian H, Kammarchedu V, Soltan Khamsi P, Brustoloni C, Ebrahimi A. Multi-Electrode Extended Gate Field Effect Transistors Based on Laser-Induced Graphene for the Detection of Vitamin C and SARS-CoV-2. ACS Appl Mater Interfaces. 2024;16:63142-63154 pubmed publisher |
Dey S, Pahari P, Mukherjee S, Munro J, Das D. Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution. Structure. 2024;32:1910-1925.e6 pubmed publisher |
Su W, Ahmad I, Wu Y, Tang L, Khan I, Ye B, et al. Furin Egress from the TGN is Regulated by Membrane-Associated RING-CH Finger (MARCHF) Proteins and Ubiquitin-Specific Protease 32 (USP32) via Nondegradable K33-Polyubiquitination. Adv Sci (Weinh). 2024;11:e2403732 pubmed publisher |
P xe9 rez Vargas J, Lemieux G, Thompson C, D xe9 silets A, Ennis S, Gao G, et al. Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals. Antiviral Res. 2024;225:105869 pubmed publisher |
Qu P, Xu K, Faraone J, Goodarzi N, Zheng Y, Carlin C, et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell. 2024;187:585-595.e6 pubmed publisher |
Fan J, Li S, Zhang Y, Zheng J, Wang D, Liao Y, et al. Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses. Viruses. 2023;15: pubmed publisher |
H xe4 ring C, Jungwirth J, Schroeder J, L xf6 ffler B, Engert B, Ehrhardt C. The Local Anaesthetic Procaine Prodrugs ProcCluster® and Procaine Hydrochloride Impair SARS-CoV-2 Replication and Egress In Vitro. Int J Mol Sci. 2023;24: pubmed publisher |
Greene K, Choi A, Chen M, Yang N, Li R, Qiu Y, et al. Inhibiting Glutamine Metabolism Blocks Coronavirus Replication in Mammalian Cells. bioRxiv. 2023;: pubmed publisher |
Liu L, Casner R, Guo Y, Wang Q, Iketani S, Chan J, et al. Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking. Immunity. 2023;56:2442-2455.e8 pubmed publisher |
Shuai H, Hu B, Chai Y, Yoon C, Liu H, Liu Y, et al. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5. EBioMedicine. 2023;95:104753 pubmed publisher |
Xu D, Jiang W, Wu L, Gaudet R, Park E, Su M, et al. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. Nature. 2023;619:819-827 pubmed publisher |
Qu P, Faraone J, Evans J, Zheng Y, Carlin C, Anghelina M, et al. Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants. Cell Rep. 2023;42:112443 pubmed publisher |
Frolov I, Agback T, Palchevska O, Dominguez F, Lomzov A, Agback P, et al. All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein. J Virol. 2023;97:e0186522 pubmed publisher |
Qu P, Evans J, Kurhade C, Zeng C, Zheng Y, Xu K, et al. Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants. MBio. 2023;14:e0317622 pubmed publisher |
Chan J, Hu B, Chai Y, Shuai H, Liu H, Shi J, et al. Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2. Cell Rep Med. 2022;3:100743 pubmed publisher |
Frolova E, Palchevska O, Lukash T, Dominguez F, Britt W, Frolov I. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. J Virol. 2022;96:e0075322 pubmed publisher |
Shuai H, Chan J, Hu B, Chai Y, Yuen T, Yin F, et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603:693-699 pubmed publisher |
Du S, Xu W, Wang Y, Li L, Hao P, Tian M, et al. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles. J Virol. 2022;96:e0189721 pubmed publisher |
Yu S, Zheng X, Zhou B, Li J, Chen M, Deng R, et al. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher |
Lubinski B, Fernandes M, Frazier L, Tang T, Daniel S, Diel D, et al. Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike. iScience. 2022;25:103589 pubmed publisher |
Kim G, Choi J, Wu K, Saeedian N, Yang E, Park H, et al. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2. PLoS Pathog. 2021;17:e1010092 pubmed publisher |
Wang Q, Nair M, Anang S, Zhang S, Nguyen H, Huang Y, et al. Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern. iScience. 2021;24:103393 pubmed publisher |
Dispinseri S, Secchi M, Pirillo M, Tolazzi M, Borghi M, Brigatti C, et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12:2670 pubmed publisher |
Deinhardt Emmer S, Böttcher S, Häring C, Giebeler L, Henke A, Zell R, et al. SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction. J Virol. 2021;: pubmed publisher |
Takeda Y, Murata T, Jamsransuren D, Suganuma K, Kazami Y, Batkhuu J, et al. Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2. Viruses. 2020;12: pubmed publisher |
